nach oben

Erschienen in:

20.10.2017 | Original Contribution

Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate

verfasst von: Lorenzo Pelizza, Silvia Azzali, Sara Garlassi, Federica Paterlini, Ilaria Scazza, Luigi Rocco Chiri, Simona Pupo, Andrea Raballo

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Studies in adolescents on ultra-high risk (UHR) and basic symptoms (BS) criteria for psychosis prediction are scarce. In Italy, early interventions in psychosis are less widespread than in other European countries. In the present study, we (1) assessed the clinical relevance of a UHR diagnosis [according to the comprehensive assessment of at-risk mental states (CAARMS) criteria] to promote the implementation of specific services for UHR adolescents into the Italian health care system; (2) described severity of positive, negative, general, and basic symptoms in UHR adolescents compared to adolescents with first-episode psychosis (FEP) and non-UHR adolescents (i.e., individuals who did not meet CAARMS criteria for UHR or FEP); and (3) investigated the predictive validity of UHR criteria in relation to BS criteria. Seventy-nine adolescents (aged 13–18 years) were assessed with the CAARMS, the positive and negative syndrome scale (PANSS), and the schizophrenia proneness instrument, child and youth version (SPI-CY). Both UHR (n = 25) and FEP (n = 11) had significantly higher PANSS subscale scores compared to non-UHR (n = 43). UHR had significantly lower PANSS-positive symptom scores than FEP, but similar global functioning and PANSS-negative symptoms and general psychopathology scores. Compared to non-UHR, both FEP and UHR had more severe thought and perception BS disturbances, and significantly more often met BS criteria. After 12 months, 2 of 20 (10%) UHR had transitioned to psychosis. They also met both BS criteria. Given the uncertain outcome of UHR adolescents, future research is needed to determine whether the combined assessment of BS with UHR symptoms can improve the accuracy of psychosis prediction in adolescence.

Armando M, Pontillo M, De Crescenzo F, Mazzone L, Monducci E, Lo Cascio N, Santonastaso O, Pucciarini ML, Vicari S, Schimmelmann BG, Schultze-Lutter F (2015) Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents. Schizophr Res 169:186–192CrossRefPubMed

Ramella-Cravaro V, Raballo A (2014) Early detection of schizophrenia: a clinical-psychopathological revision of ultra-high risk approach. J Psychopathol 20:442–450

Schultze-Lutter F, Michel C, Schmidt SJ, Schimmelmenn BG, Maric NP, Salokangas RKR, Reicher-Rossler A, Van der Gaag M, Nordentoft M, Raballo A, Meneghelli A, Marshall M, Morrison A, Ruhrmann S, Klosterkotter J (2015) EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry 30:388–404PubMed

Yung A, Nelson B (2013) The ultra-high risk concept: a review. Can J Psychiatry 58:5–12CrossRefPubMed

Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F (2001) Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 58:158–164CrossRefPubMed

Maggini C, Raballo A, Pelizza L, Paini M, Croci R (2003) Subjective experience of language impairment and psychopathology in schizophrenia. Psychopathology 36:17–22CrossRefPubMed

Pelizza L, Pupo S (2013) Obsessive-compulsive disorder with psychotic features: psychopathological and personological aspects. Riv Psichiatr 48:224–233PubMed

Pelizza L, Pupo S (2015) Basic symptoms in obsessive–compulsive disorder. J Psychopathol 21:62–71

Gross G (1989) The “basic” symptoms of schizophrenia. Br J Psychiatry Suppl (7):21–25 (discussion 37–40)

10.

Lo Cascio N, Saba R, Hauser M, Vernal DL, Al-Jadiri A, Borenstein Y, Sheridan EM, Fiori Nastro P, Girardi P, Gebhardt E, Kane JM, Auther A, Carrion RE, Cornblatt BA, Schimmelmann BG, Schultze-Lutter F, Correll CU (2016) Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis. Eur Child Adolesc Psychiatry 25:1091–1102CrossRefPubMed

11.

Welsh P, Tiffin PA (2014) The “at-risk mental state” for psychosis in adolescents: clinical presentation, transition and remission. Child Psychiatry Hum Dev 45:90–98CrossRefPubMed

12.

Schimmelmann BG, Michel C, Martz-Irngartinger A (2015) Age matters in the prevalence and clinical significance of ultra-high risk for psychosis and criteria in the general population: findings from the BEAR and BEARS-kid study. World Psychiatry 14:189–197CrossRefPubMedPubMedCentral

13.

Schultze-Lutter F, Klosterkotter J, Ruhrmann S (2014) Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res 154:100–106CrossRefPubMed

14.

Spada G, Molteni S, Pistone C, Chiappedi M, McGuire P, Fusar-Poli P, Balottin U (2016) Identifying children and adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: a feasibility study. Eur Child Adolesc Psychiatry 25:91–106CrossRefPubMed

15.

Fiori NP, Schimmelmann BG, Gebhardt E, Monducci E, Resch F, Koch E, Schultze-Lutter F (2012) Challenges in the early detection of psychosis in children and adolescents. Riv Psychiatry 47:116–125

16.

Rubio JM, Sanjuan J, Florez-Salamanca L, Cuesta MJ (2012) Examining the course of hallucinatory experiences in children and adolescents: a systematic review. Schizophr Res 138:248–254CrossRefPubMed

17.

Kelleher J, Connor D, Clarke MC, Devlin N, Harley M, Cannon M (2012) Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies. Psychol Med 42:1857–1863CrossRefPubMed

18.

Kaymaz N, Drukker M, Lieb R, Wittchen HU, Werbeloff N, Weiser M, Lataster T, van Os J (2012) Do sub-threshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? A systematic review and meta-analysis, enriched with new results. Psychol Med 42:2239–2253CrossRefPubMed

19.

Cocchi A, Meneghelli A, Preti A (2008) Programma 2000: celebrating 10 years of activity of an Italian pilot programme on early intervention in psychosis. Aust N Z J Psychiatry 42:1003–1012CrossRefPubMed

20.

Raballo A, Chiri LR, Pelizza L, Semrov E et al (2014) Field-testing the early intervention paradigm in Emilia-Romagna: the Reggio Emilia at risk mental state (ReARMS) Project. Early Interv Psychiatry 8(suppl.):88

21.

Raballo A, Semrov E, Bonner Y, Simmons MB. Traduzione e adattamento italiano della CAARMS (the Comprehensive Assessment of At Risk Mental States). Regione Emilia-Romagna, Bologna

22.

Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J (2005) Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39:964–971CrossRefPubMed

23.

Andreoli V, Cassano GB, Rossi R (2002) DSM-IV-TR: Manuale Diagnostico e Statistico dei Disturbi Mentali, IV Edizione, Text Revised. Masson, Milano

24.

Conti L (1999) Repertorio delle scale di valutazione in psichiatria. SEE, Firenze

25.

Schultze-Lutter F, Koch E (2010) Strumento di valutazione per la propensione alla schizophrenia, versione per bambini e adolescenti (SPI-CY). Giovanni Fioriti Editore, Roma

26.

Huang M, Huang Y, Yu L (2016) Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia. BMC Psychiatry 16:344–354CrossRefPubMedPubMedCentral

27.

Fux L, Walger P, Schimmelmann BG, Schultze-Lutter F (2013) The schizophrenia proneness instrument, child and youth version (SPI-CY): practicability and discriminant validity. Schizophr Res 146:69–78CrossRefPubMed

28.

Rapp C, Canela C, Studeros E, Walter A, Aston J, Borgwardt S, Riecher-Rossler A (2017) Duration of untreated illness and brain volume changes in early psychosis. Psychiatry Res 255:332–337CrossRefPubMed

29.

Schimmelmann BG, Walger P, Schultze-Lutter F (2013) The significance of at-risk symptoms for psychosis in children and adolescents. Can J Psychiatry 58:32–40CrossRefPubMed

30.

Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P (2012) Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 69:220–229CrossRefPubMed

31.

Kelleher J, Keeley H, Corcoran P, Lynch F, Fizpatrick C, Devlin N, Molloy C, Roddy S, Clarke MC, Harley M, Arseneault L, Wasserman C, Carli V, Sarchiapone M, Hoven C, Wasserman D, Cannon M (2012) Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry 201:26–32CrossRefPubMed

32.

Fusar-Poli P, Byrne M, Valmaggia L, Day F, Tabraham P, Johns L, McGuire P (2010) Social dysfunctioning predicts 2 years clinical outcome in people at ultra-high risk for psychosis. J Psychiatry Res 44:294–301CrossRef

33.

Ruhrmann S, Schiltze-Lutter F, Klosterkotter J (2010) Probably at-risk, but certainly ill-advocating the introduction of a psychosis-spectrum disorder in DSM-V. Schizophr Res 120:23–37CrossRefPubMed

34.

Olvet DM, Stearns WH, McLaughlin D, Auther AM, Correll CU, Cornblatt BA (2010) Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodrome. Schizophr Res 123:59–63CrossRefPubMedPubMedCentral

35.

Correll CU, Hauser M, Penzner JB, Auther AM, Kafantaris V, Saito E, Olvet D, Carrion RE, Birmaher B, Chang KD, Del Bello MP, Singh MK, Pavuluri M, Cornblatt BA (2014) Type and duration of sub-syndromal symptoms in youth with bipolar I disorder before their first manic episode. Bipolar Disord 16:487–492

36.

Salvatore P, Baldessarini RJ, Khalsa HMK, Vazquez Perez J, Faedda JL, Amore M, Maggini C, Tohen M (2014) Antecedents of manic versus other first psychotic episodes in 263 bipolar I disorder patients. Acta Psychiatr Scand 129:275–285CrossRefPubMed

37.

Van Meter AR, Burke C, Youngstrom EA, Faedda GL, Correll CU (2016) The bipolar prodrome: meta-analysis of symptom prevalence prior to initial or recurrent mood episode. J Am Acad Child Adolesc Psychiatry 55:543–555CrossRefPubMed

38.

Seidman LJ, Giuliano AJ, Meyer EC (2010) Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry 67:578–588CrossRefPubMedPubMedCentral

39.

Haefner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkotter J, Wagner M, Maier W, Bottlender R, Moller HJ, Gaebel W, Wolwer W (2004) Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 254:117–128CrossRef

40.

Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson PV, Salokangas RK, Heinimaa M, Heinz A, French P, Stevens H, Schultze-Lutter F, Klosterkotter J, Ruhrmann S (2010) Disability in people clinically at high risk of psychosis. Br J Psychiatry 197:278–284CrossRefPubMed

41.

McGorry PD, Nelson B, Amminger GP et al (2009) Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry 70:1206–1212CrossRefPubMed

42.

Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, McGlashan TH (2012) Negative symptoms in individuals at clinical risk of psychosis. Psychiatry Res 196:220–224CrossRefPubMedPubMedCentral

43.

Nelson B, Yuen HP, Woods SJ, Lin A, Spiliotacopoulos S, Bruxner A, Broussard C, Simmons M, Foley DL, Brewer WJ, Francey SM, Amminger JP, Thompson A, McGorry PD, Yung AR (2013) Long-term follow-up of a group at ultra-high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiatry 70:793CrossRefPubMed

44.

Ziermans TB, Schothorst PF, Sprong M, van Engeland H (2011) Transition and remission in adolescents at ultra-high risk for psychosis. Schizophr Res 126:58–64CrossRefPubMed

45.

Finnerty M, Neese-Todd S, Pritam R (2016) Access to psychosocial services prior to starting antipsychotic treatment among medicaid-insured youth. J Am Acad Child Adolesc Psychiatry 55:69–76CrossRefPubMed

46.

Correll CU (2008) Assessing and minimizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. JAMA 302:1765–1773CrossRef

47.

Meng H, Schimmelmann BG, Koch E et al (2009) Basic symptoms in the general population and in psychotic and non-psychotic psychiatric adolescents. Schizophr Res 111:32–38CrossRefPubMed

48.

Cannon TD, Cadenhead K, Cornblatt B et al (2008) Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 65:28–37CrossRefPubMedPubMedCentral

49.

Fusar-Poli P, Bechdolf A, Taylor MJ et al (2013) At-risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull 39:923–932CrossRefPubMed

Titel: Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate
verfasst von: Lorenzo Pelizza
Silvia Azzali
Sara Garlassi
Federica Paterlini
Ilaria Scazza
Luigi Rocco Chiri
Simona Pupo
Andrea Raballo
Publikationsdatum: 20.10.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Child & Adolescent Psychiatry / Ausgabe 6/2018
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-017-1070-3

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Clinical high risk for psychosis in children and adolescents: a systematic review

Peer status in relation to psychotic experiences and psychosocial problems in adolescents: a longitudinal school-based study

Predictive validity of a service-setting-based measure to identify infancy mental health problems: a population-based cohort study